Instrumented assessment of gait disturbance in PMM2-CDG adults: a feasibility analysis

Lara Cirnigliaro,Fabio Pettinato,Maria Stella Valle,Antonino Casabona,Agata Fiumara,Michele Vecchio,Valerio Amico,Renata Rizzo,Jaak Jaeken,Rita Barone,Matteo Cioni
DOI: https://doi.org/10.1186/s13023-024-03027-x
2024-02-04
Orphanet Journal of Rare Diseases
Abstract:Congenital disorders of glycosylation (CDG) are genetic diseases caused by impaired synthesis of glycan moieties linked to glycoconjugates. Phosphomannomutase 2 deficiency (PMM2-CDG), the most frequent CDG, is characterized by prominent neurological involvement. Gait disturbance is a major cause of functional disability in patients with PMM2-CDG. However, no specific gait assessment for PMM2-CDG is available. This study analyses gait-related parameters in PMM2-CDG patients using a standardized clinical assessment and instrumented gait analysis (IGA).
genetics & heredity,medicine, research & experimental
What problem does this paper attempt to address?